8-K Announcements
6Material company update
Apr 7, 2026·SEC
Material company update
Feb 13, 2026·SEC
Material company update
Feb 3, 2026·SEC
Nutriband Inc.(NTRB)Earnings, Financials & Key Ratios
NTRB•NASDAQ
Price updated Jun 19, 2026
AboutNutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Show more
- Revenue$2M-4.8%
- EBITDA-$8M-26.8%
- Net Income-$8M+21.5%
- EPS (Diluted)-2.58-160.6%
- Gross Margin25.68%-21.4%
- EBITDA Margin-398.9%-33.3%
- Operating Margin-408.41%-30.6%
- Net Margin-404.08%+17.5%
- ROE-125.56%+22.9%
NTRB Key Insights
Nutriband Inc. (NTRB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 16.6%
✗Weaknesses
- ✗Profits declining 20.7% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 10 (bottom 10%)
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NTRB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NTRB Price & Volume
Nutriband Inc. (NTRB) stock price & volume — 10-year historical chart
Loading chart...
NTRB Growth Metrics
Nutriband Inc. (NTRB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years16.63%
3 Years-0.69%
TTM-24.84%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM18.95%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-191.07%
Return on Capital
10 Years-355.09%
5 Years-74.65%
3 Years-97.47%
Last Year-125.55%
NTRB Peer Comparison
Nutriband Inc. (NTRB) competitors in Drug Delivery Technology Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DARE | 31.51M | 2.17 | -1.81 | 104.29% | -10.39% | -471.37% | 0.93 | |
 AVDL | 2.1B | 21.64 | -42.43 | 5.05% | -0.11% | -0.33% | 0.02 | |
 MTUS | 805.81M | 19.31 | -675.17 | 6.85% | 0.24% | 0.42% | 0.02 | |
 CLRB | 8.91M | 2.79 | -0.33 | -264.79% | 0.04 | |||
 PRGO | 1.42B | 10.25 | -1.00 | -2.75% | -43.5% | -50.65% | 1.35 | |
 LPCN | 12.69M | 2.33 | -1.38 | -82.35% | -5.71% | -66.69% | ||
 NKTR | 1.19B | 60.98 | -6.27 | -43.89% | -284.18% | -87% | 1.66 | |
 HALO | 8.13B | 68.55 | 26.78 | 37.55% | 23.13% | 126.27% | 43.89 |
Compare NTRB vs Peers
Nutriband Inc. (NTRB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NTRB Income Statement
Nutriband Inc. (NTRB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 245.28K | 370.65K | 943.7K | 1.42M | 2.08M | 2.09M | 2.14M | 2.04M | 1.8M |
Revenue Growth % | - | - | 51.11% | 154.61% | 50.7% | 46.23% | 0.27% | 2.62% | -4.83% | -24.84% |
Cost of Goods Sold | 0 | 288.3K | 549.11K | 582.38K | 917.84K | 1.33M | 1.22M | 1.44M | 1.51M | 1.33M |
COGS % of Revenue | - | 117.54% | 148.15% | 61.71% | 64.54% | 63.92% | 58.66% | 67.29% | 74.32% | - |
Gross Profit | 0▲ 0% | -43.02K▲ 0% | -178.46K▼ 314.9% | 361.32K▲ 302.5% | 504.31K▲ 39.6% | 750.41K▲ 48.8% | 862.11K▲ 14.9% | 699.3K▼ 18.9% | 523.11K▼ 25.2% | 476.57K▲ 0% |
Gross Margin % | - | -17.54% | -48.15% | 38.29% | 35.46% | 36.08% | 41.34% | 32.68% | 25.68% | 26.44% |
Gross Profit Growth % | - | - | -314.87% | 302.47% | 39.57% | 48.8% | 14.88% | -18.88% | -25.2% | - |
Operating Expenses | 171.95K | 3.29M | 1.79M | 2.96M | 4.43M | 4.9M | 5.73M | 7.39M | 8.84M | 8.64M |
OpEx % of Revenue | - | 1340.57% | 483.2% | 313.37% | 311.8% | 235.54% | 274.97% | 345.28% | 434.1% | - |
Selling, General & Admin | 171.95K | 3.29M | 1.79M | 2.96M | 4.02M | 3.92M | 3.77M | 4.27M | 6.95M | 7.18M |
SG&A % of Revenue | - | 1340.57% | 483.2% | 313.37% | 282.87% | 188.31% | 180.96% | 199.53% | 341.24% | - |
Research & Development | 0 | 0 | 0 | 0 | 411.38K | 982.23K | 1.96M | 3.12M | 1.89M | 1.45M |
R&D % of Revenue | - | - | - | - | 28.93% | 47.23% | 94.01% | 145.75% | 92.85% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -171.95K▲ 0% | -3.33M▼ 1837.4% | -1.97M▲ 40.9% | -2.6M▼ 31.8% | -3.93M▼ 51.4% | -4.15M▼ 5.5% | -4.87M▼ 17.5% | -6.69M▼ 37.3% | -8.32M▼ 24.3% | -8.16M▲ 0% |
Operating Margin % | - | -1358.11% | -531.35% | -275.08% | -276.33% | -199.45% | -233.63% | -312.62% | -408.41% | -452.61% |
Operating Income Growth % | -13.68% | -1837.38% | 40.88% | -31.81% | -51.39% | -5.55% | -17.46% | -37.32% | -24.33% | - |
EBITDA | -24.69K | -3.29M | -1.88M | -2.43M | -3.61M | -3.78M | -4.58M | -6.4M | -8.12M | -7.99M |
EBITDA Margin % | - | -1343.02% | -506.57% | -257.1% | -253.96% | -181.71% | -219.83% | -299.3% | -398.9% | -443.16% |
EBITDA Growth % | - | -13244.52% | 43% | -29.22% | -48.86% | -4.63% | -21.31% | -39.72% | -26.84% | -34.46% |
D&A (Non-Cash Add-back) | 147.26K | 37.01K | 91.84K | 169.72K | 318.26K | 368.96K | 287.72K | 285.05K | 193.8K | 170.39K |
EBIT | -2.67M | -3.33M | -2.65M | -2.65M | -6.06M | -4.48M | -5.41M | -10.46M | -8.32M | -8.16M |
Net Interest Income | 0 | 0 | -73.41K | -349.82K | -118.42K | -8.29K | -58.97K | 170.26K | 88.33K | 76.1K |
Interest Income | 0 | 0 | 0 | 280.69K | 0 | 0 | 16.85K | 191.67K | 110.86K | 97.76K |
Interest Expense | 0 | 0 | 73.41K | 280.69K | 118.42K | 8.29K | 75.81K | 21.41K | 22.54K | 11.65K |
Other Income/Expense | -2.5M | 0 | -752.19K | -336.88K | -2.25M | -335.62K | -613.39K | -3.79M | 88.33K | 76.1K |
Pretax Income | -2.67M▲ 0% | -3.33M▼ 24.7% | -2.72M▲ 18.3% | -2.93M▼ 7.8% | -6.18M▼ 110.6% | -4.48M▲ 27.4% | -5.49M▼ 22.3% | -10.48M▼ 91.1% | -8.23M▲ 21.5% | -8.08M▲ 0% |
Pretax Margin % | - | -1358.11% | -734.29% | -310.78% | -434.28% | -215.59% | -263.05% | -489.86% | -404.08% | -448.39% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -2.67M▲ 0% | -3.33M▼ 24.7% | -2.8M▲ 16.1% | -3.21M▼ 15.0% | -8.42M▼ 162.1% | -4.81M▲ 42.9% | -5.49M▼ 14.0% | -10.48M▼ 91.1% | -8.23M▲ 21.5% | -8.08M▲ 0% |
Net Margin % | - | -1358.11% | -754.1% | -340.52% | -592.23% | -231.33% | -263.05% | -489.86% | -404.08% | -448.39% |
Net Income Growth % | -1666.46% | -24.67% | 16.1% | -14.97% | -162.09% | 42.88% | -14.02% | -91.11% | 21.5% | 18.95% |
Net Income (Continuing) | -2.67M | -3.33M | -2.72M | -2.93M | -6.18M | -4.48M | -5.49M | -10.48M | -8.23M | -8.08M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.48▲ 0% | -0.53▼ 10.4% | -0.44▲ 17.0% | -0.48▼ 9.1% | -1.06▼ 120.8% | -0.57▲ 46.2% | -0.69▼ 21.1% | -0.99▼ 43.5% | -2.58▼ 160.6% | -0.66▲ 0% |
EPS Growth % | -1820% | -10.42% | 16.98% | -9.09% | -120.83% | 46.23% | -21.05% | -43.48% | -160.61% | -191.07% |
EPS (Basic) | -0.48 | -0.53 | -0.44 | -0.48 | -1.06 | -0.57 | -0.69 | -0.99 | -2.58 | - |
Diluted Shares Outstanding | 5.6M | 6.24M | 6.33M | 6.73M | 7.93M | 8.46M | 7.95M | 10.61M | 11.64M | 12.16M |
Basic Shares Outstanding | 5.6M | 6.24M | 6.33M | 6.73M | 7.93M | 8.46M | 7.95M | 10.61M | 11.64M | 12.16M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NTRB Balance Sheet
Nutriband Inc. (NTRB) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 164.9K | 590.47K | 43.18K | 314.19K | 5.47M | 2.69M | 1.02M | 4.79M | 4.99M | 4.38M |
Cash & Short-Term Investments | 0 | 474.65K | 10.18K | 151.99K | 4.89M | 1.99M | 492.94K | 4.31M | 4.57M | 4.01M |
Cash Only | 0 | 474.65K | 10.18K | 151.99K | 4.89M | 1.99M | 492.94K | 4.31M | 4.57M | 4.01M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 263 | 13.09K | 12.83K | 109.35K | 71.38K | 113.05K | 148.65K | 73.85K | 118.4K | 2.63K |
Days Sales Outstanding | - | 19.48 | 12.64 | 42.29 | 18.32 | 19.84 | 26.02 | 12.6 | 21.22 | 21.74 |
Inventory | 4.13K | 0 | 0 | 52.85K | 131.65K | 229.34K | 168.6K | 212.04K | 117.99K | 121.49K |
Days Inventory Outstanding | - | - | 0 | 33.12 | 52.35 | 62.98 | 50.31 | 53.75 | 28.45 | 35.34 |
Other Current Assets | 0 | 102.72K | 0 | 0 | 0 | 0 | 0 | -546 | 0 | 0 |
Total Non-Current Assets | 0 | 2.22M | 2.15M | 9.61M | 7.27M | 6.76M | 6.5M | 2.68M | 2.56M | 2.52M |
Property, Plant & Equipment | 0 | 146.15K | 120.64K | 1.08M | 998.34K | 960.49K | 806.3K | 695.06K | 639.25K | 611.24K |
Fixed Asset Turnover | - | 1.68x | 3.07x | 0.88x | 1.42x | 2.17x | 2.59x | 3.08x | 3.19x | 2.75x |
Goodwill | 0 | 1.72M | 1.72M | 7.53M | 5.35M | 5.02M | 5.02M | 1.72M | 1.72M | 1.72M |
Intangible Assets | 0 | 351.77K | 314.7K | 1.01M | 926.91K | 780.43K | 667.28K | 261.09K | 200.43K | 185.26K |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -63 | 0 | 0 |
Total Assets | 164.9K▲ 0% | 2.81M▲ 1602.6% | 2.2M▼ 21.7% | 9.93M▲ 351.7% | 12.74M▲ 28.3% | 9.46M▼ 25.8% | 7.52M▼ 20.5% | 7.47M▼ 0.6% | 7.55M▲ 1.0% | 6.89M▲ 0% |
Asset Turnover | - | 0.09x | 0.17x | 0.10x | 0.11x | 0.22x | 0.28x | 0.29x | 0.27x | 0.22x |
Asset Growth % | 337.08% | 1602.63% | -21.72% | 351.71% | 28.33% | -25.77% | -20.51% | -0.63% | 1.04% | -45.16% |
Total Current Liabilities | 43.39K | 403.01K | 2.02M | 2.57M | 779.26K | 748.61K | 999.09K | 982.85K | 784.28K | 832.14K |
Accounts Payable | 12.34K | 291.78K | 771.93K | 0 | 0 | 0 | 680.13K | 698.82K | 502.65K | 639.19K |
Days Payables Outstanding | - | 369.41 | 513.11 | - | - | - | 202.95 | 177.13 | 121.22 | 85.63 |
Short-Term Debt | 31.05K | 40K | 311.57K | 1.52M | 14.12K | 19.74K | 127.18K | 128.14K | 161.32K | 162.54K |
Deferred Revenue (Current) | -43.39K | 71.22K | 0 | 86.85K | 106.27K | 162.9K | 157.5K | 155.88K | 120.3K | 177.1K |
Other Current Liabilities | 0 | 0 | 928.77K | 940.61K | 639.54K | 534.68K | 0 | 0 | 0 | 0 |
Current Ratio | 3.80x | 1.47x | 0.02x | 0.12x | 7.01x | 3.60x | 1.02x | 4.88x | 6.36x | 5.26x |
Quick Ratio | 3.71x | 1.47x | 0.02x | 0.10x | 6.84x | 3.29x | 0.85x | 4.66x | 6.21x | 5.11x |
Cash Conversion Cycle | - | - | -500.48 | - | - | - | -126.62 | -110.79 | -71.55 | -28.56 |
Total Non-Current Liabilities | 0 | 0 | 0 | 246.87K | 101.12K | 134.77K | 79.83K | 58.2K | 84.17K | 70.17K |
Long-Term Debt | 0 | 0 | 0 | 150.06K | 101.12K | 100.5K | 79.83K | 58.2K | 48.3K | 29.82K |
Capital Lease Obligations | 0 | 0 | 0 | 96.8K | 0 | 34.28K | 0 | 0 | 48.3K | 104.03K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 43.39K | 403.01K | 2.02M | 2.82M | 880.38K | 883.39K | 1.08M | 1.04M | 868.45K | 902.31K |
Total Debt | 31.05K | 40K | 321.62K | 1.79M | 134.57K | 185.81K | 241.28K | 186.35K | 209.63K | 232.71K |
Net Debt | 31.05K | -434.65K | 311.44K | 1.64M | -4.76M | -1.8M | -251.66K | -4.13M | -4.37M | -3.77M |
Debt / Equity | 0.26x | 0.02x | 1.83x | 0.25x | 0.01x | 0.02x | 0.04x | 0.03x | 0.03x | 0.04x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.03x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.47x |
Interest Coverage | - | - | -36.07x | -9.45x | -51.15x | -539.89x | -71.35x | -488.67x | -369.11x | -700.51x |
Total Equity | 121.51K▲ 0% | 2.4M▲ 1879.0% | 175.43K▼ 92.7% | 7.11M▲ 3953.9% | 11.86M▲ 66.8% | 8.57M▼ 27.7% | 6.44M▼ 24.9% | 6.43M▼ 0.1% | 6.68M▲ 3.9% | 5.99M▲ 0% |
Equity Growth % | 425.8% | 1878.97% | -92.7% | 3953.94% | 66.75% | -27.71% | -24.9% | -0.14% | 3.9% | -43.35% |
Book Value per Share | 0.02 | 0.39 | 0.03 | 1.06 | 1.49 | 1.01 | 0.81 | 0.61 | 0.57 | 0.49 |
Total Shareholders' Equity | 121.51K | 2.4M | 175.43K | 7.11M | 11.86M | 8.57M | 6.44M | 6.43M | 6.68M | 5.99M |
Common Stock | 20.88K | 21.7K | 5.44K | 6.26K | 9.15K | 7.83K | 8.86K | 11.07K | 12.16K | 12.16K |
Retained Earnings | -2.85M | -6.18M | -8.9M | -11.84M | -18.01M | -22.49M | -27.98M | -38.46M | -46.69M | -47.93M |
Treasury Stock | 0 | 0 | 0 | 0 | -104.47K | -32.64K | -32.64K | -149K | -86.85K | -86.85K |
Accumulated OCI | -446 | -52 | -304 | -304 | -304 | -304 | -304 | -304 | -304 | -304 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NTRB Cash Flow Statement
Nutriband Inc. (NTRB) cash flow — operating, investing & free cash flow history
| Metric | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -92.86K | -1.11M | -894.47K | -297.06K | -2.81M | -2.99M | -3.53M | -4.63M | -5.13M | -4.36M |
Operating CF Margin % | - | -450.69% | -241.33% | -31.48% | -197.53% | -143.64% | -169.16% | -216.22% | -252.11% | - |
Operating CF Growth % | 37.23% | -1090.49% | 19.09% | 66.79% | -845.69% | -6.34% | -18.09% | -31.17% | -10.97% | 40.24% |
Net Income | -2.67M | -3.33M | -2.72M | -2.93M | -6.18M | -4.48M | -5.49M | -10.48M | -8.23M | -8.08M |
Depreciation & Amortization | 0 | 37.01K | 91.41K | 169.72K | 318.26K | 368.96K | 287.72K | 285.05K | 193.8K | 170.49K |
Stock-Based Compensation | 0 | 1.76M | 252.7K | 2M | 897.83K | 732.13K | 742.7K | 1.54M | 104.4K | 3.23M |
Deferred Taxes | 0 | 0 | 678.77K | -12.93K | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 2.5M | 24.3K | 91.32K | 363.89K | 2.23M | 614.51K | 704.17K | 3.99M | 2.67M | 36K |
Working Capital Changes | 75.09K | 400.51K | 712.96K | 110.23K | -541.38K | -219.32K | 223.22K | 34.09K | 126.81K | 287.96K |
Change in Receivables | 0 | -12.82K | 255 | -94.75K | 42.97K | -41.66K | -153.97K | 74.8K | -44.56K | 91.5K |
Change in Inventory | 3.92K | 4.13K | -720.15K | -10.23K | -78.8K | -97.69K | 60.73K | -43.44K | 94.05K | 93.83K |
Change in Payables | 4K | 337.98K | 720.15K | 155.22K | -145.26K | -104.86K | 198.89K | 23.61K | 120.94K | 234.63K |
Cash from Investing | 92.89K | -404.16K | 0 | 66.99K | -81.59K | -79.3K | -51.76K | -92.04K | -5.32K | 5.32K |
Capital Expenditures | 0 | -4.16K | 0 | 0 | -81.59K | -79.3K | -51.76K | -92.04K | -5.32K | 5.32K |
CapEx % of Revenue | - | 1.7% | - | - | 5.74% | 3.81% | 2.48% | 4.3% | 0.26% | 0.3% |
Acquisitions | 0 | -400K | 0 | 66.99K | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | -404.16K | 0 | 66.99K | -81.59K | -79.3K | 0 | 0 | 0 | 0 |
Cash from Financing | 65.76K | 1.98M | 430.25K | 371.87K | 7.63M | 160.07K | 2.09M | 8.54M | 5.4M | 5.4M |
Debt Issued (Net) | 7.51K | 22.42K | 425K | -161.54K | -1.63M | -17.8K | 2.09M | 8.69M | -21.62K | -21.86K |
Equity Issued (Net) | 50K | 1.5M | 0 | 515.11K | 6.31M | -119.01K | 0 | -149K | 5.42M | 5.42M |
Dividends Paid | 0 | 0 | 0 | 0 | -196.59K | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | -104.47K | -119.01K | 0 | -149K | 0 | 0 |
Other Financing | 8.25K | 461.47K | 5.25K | 18.31K | 3.14M | 296.88K | 0 | 69 | 0 | 0 |
Net Change in Cash | 65.76K▲ 0% | 474.65K▲ 621.8% | -464.47K▼ 197.9% | 141.81K▲ 130.5% | 4.74M▲ 3242.4% | -2.91M▼ 161.3% | -1.49M▲ 48.6% | 3.82M▲ 355.9% | 263.14K▼ 93.1% | 1.04M▲ 0% |
Free Cash Flow | -92.86K▲ 0% | -1.11M▼ 1095.0% | -894.47K▲ 19.4% | -297.06K▲ 66.8% | -2.89M▼ 873.2% | -3.07M▼ 6.1% | -3.58M▼ 16.7% | -4.72M▼ 31.8% | -5.13M▼ 8.8% | -4.36M▲ 0% |
FCF Margin % | - | -452.38% | -241.33% | -31.48% | -203.27% | -147.46% | -171.64% | -220.51% | -252.11% | -241.62% |
FCF Growth % | 37.23% | -1094.97% | 19.39% | 66.79% | -873.16% | -6.08% | -16.72% | -31.84% | -8.81% | 16.5% |
FCF per Share | -0.02 | -0.18 | -0.14 | -0.04 | -0.36 | -0.36 | -0.45 | -0.44 | -0.44 | -0.36 |
FCF Conversion (FCF/Net Income) | 0.03x | 0.33x | 0.32x | 0.09x | 0.33x | 0.62x | 0.64x | 0.44x | 0.62x | 0.54x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NTRB Key Ratios
Nutriband Inc. (NTRB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -3695.2% | -263.74% | -216.67% | -88.19% | -88.79% | -47.09% | -73.08% | -162.94% | -125.56% | -112.6% |
Return on Invested Capital (ROIC) | -162.2% | -235.42% | -120.24% | -42.17% | -37.19% | -44.84% | -56.39% | -118.2% | -270.2% | -279.63% |
Gross Margin | - | -17.54% | -48.15% | 38.29% | 35.46% | 36.08% | 41.34% | 32.68% | 25.68% | 26.44% |
Net Margin | - | -1358.11% | -754.1% | -340.52% | -592.23% | -231.33% | -263.05% | -489.86% | -404.08% | -448.39% |
Debt / Equity | 0.26x | 0.02x | 1.83x | 0.25x | 0.01x | 0.02x | 0.04x | 0.03x | 0.03x | 0.04x |
Interest Coverage | - | - | -36.07x | -9.45x | -51.15x | -539.89x | -71.35x | -488.67x | -369.11x | -700.51x |
FCF Conversion | 0.03x | 0.33x | 0.32x | 0.09x | 0.33x | 0.62x | 0.64x | 0.44x | 0.62x | 0.54x |
Revenue Growth | - | - | 51.11% | 154.61% | 50.7% | 46.23% | 0.27% | 2.62% | -4.83% | -24.84% |
Related:NTRB Dividend History·NTRB Revenue History·NTRB Price History·NTRB P/E History·NTRB Financial Ratios·NTRB Institutional Holders
NTRB SEC Filings & Documents
Nutriband Inc. (NTRB) SEC filings — annual & quarterly reports (10-K, 10-Q)
NTRB Frequently Asked Questions
Nutriband Inc. (NTRB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Nutriband Inc. (NTRB) reported $1.8M in revenue for fiscal year 2025.
Nutriband Inc. (NTRB) saw revenue decline by 4.8% over the past year.
Nutriband Inc. (NTRB) reported a net loss of $8.1M for fiscal year 2025.
Dividend & Returns
Nutriband Inc. (NTRB) has a return on equity (ROE) of -125.6%. Negative ROE indicates the company is unprofitable.
Nutriband Inc. (NTRB) had negative free cash flow of $4.4M in fiscal year 2025, likely due to heavy capital investments.